|
|
|
|
|
|
Myovant Sciences Ltd (MYOV)
|
|
13.54 +0.04 (+0.30%)
|
10/19/2017 3:58pm
|
|
Open:
|
13.50
|
Pre. Close:
|
13.50
|
|
High:
|
13.75
|
Low:
|
13.25
|
|
Volume:
|
12,291
|
Market Cap:
|
823.83M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
14.32 - 14.61
|
14.61 - 14.9
|
|
Low:
|
12.37 - 12.87
|
12.87 - 13.38
|
|
Close:
|
12.87 - 13.45
|
13.45 - 14.04
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-19 3:28:25 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 18.73 One year: 22.02
|
|
Support:
|
Support1: 11.49 Support2: 9.56
|
|
Resistance:
|
Resistance1:
16.04 Resistance2: 18.85
|
|
Pivot:
|
14.83 
|
|
Moving Averages:
|
MA(5): 14.16 MA(20): 14.61 
MA(100): 12.66 MA(250):
|
|
MACD:
|
MACD(12,26):
0.25 Signal(12,26,9): 0.50
|
|
%K %D:
|
%K(14,3): 5.48 %D(3): 18.46
|
|
RSI:
|
RSI(14): 45.60
|
|
52-Week:
|
High: 18.85
Low: 9.92 Change(%): 2.5
|
|
Average Vol(K):
|
3-Month: 4412
10-Days 1877
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.MYOV has closed above bottom band by 7.7%. Bollinger Bands are 10.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Wed, 05 Oct 2016 18:56:36 GMT
13.97
Thu, 27 Oct 2016 03:56:15 GMT
Myovant Sciences Ltd. Announces Pricing of Initial Public Offering
Thu, 14 Sep 2017 04:07:30 GMT
Myovant Sciences (MYOV) Presents at Baird's 2017 Global Healthcare Conference ...
Mon, 16 Oct 2017 12:45:00 GMT
Myovant Sciences Secures Flexible Financing Commitments of up to $140 Million
Wed, 25 Jan 2017 12:00:00 GMT
Myovant Sciences Initiates Phase 3 Clinical Program of Relugolix in Women With ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
